Form 4: VeriSign Chief Exec Trims Stake with $2.5M Share Sale

Rhea-AI Filing Summary

Verisign Inc. (VRSN) – Form 4 insider transaction filing dated 20-Jun-2025

D. James Bidzos, Executive Chairman, President & CEO and a director of Verisign, reported open-market sales of the company’s common stock over two consecutive trading days.

• Transaction dates: 17-Jun-2025 and 18-Jun-2025
• Total shares sold: 9,000
• Price range: $280.00 – $285.15 per share; weighted-average prices disclosed for each block
• Proceeds (approx.): $2.54 million at the stated weighted-average prices
• Post-sale beneficial ownership: 531,771.6215 shares, down from 540,271.6215 – a reduction of about 1.6%
• Ownership form: Direct
• Derivative securities: None reported

No indication was provided that the trades were executed under a Rule 10b5-1 trading plan, and the filing shows no derivative activity. The Form 4 was signed on behalf of Bidzos by Thomas C. Indelicarto under power of attorney.

The filing is routine but noteworthy because it involves the company’s longtime chief executive. While the volume sold represents a small fraction of his holdings, any insider disposition draws investor attention to potential motivations and the executive’s outlook. The company did not release concurrent earnings or operational updates within this document.

Positive

• Executive still holds 531,772 shares, indicating continued significant equity alignment with shareholders.
• Sale executed at near all-time price levels (~$281-$285), implying management confidence in monetizing shares without discount.

Negative

• CEO disposed of 9,000 shares, reducing direct stake by about 1.6%, which could be perceived as a slight bearish signal.
• No disclosure of a Rule 10b5-1 plan, leaving motives for the sale open to interpretation.

Insights

Securities Analyst

TL;DR: CEO sold 9k VRSN shares (~1.6% stake) at ~$281-$285; modest size, routine Form 4, signal impact likely limited.

Bidzos’ sales totaled roughly $2.5 million and leave him holding more than 530k shares. The reduction is small relative to his position and below thresholds that typically trigger strong sentiment changes. No accompanying derivative hedges or option exercises were reported, suggesting straightforward profit-taking. Absent evidence of a 10b5-1 plan or strategic need for liquidity, markets may initially view the action as mildly bearish, yet the limited volume versus average daily turnover diminishes pricing impact. Investors should monitor future filings for pattern consistency.

Corporate Governance Specialist

TL;DR: Insider disposition by dual-role chair/CEO merits monitoring but is immaterial to control and governance structure.

Bidzos retains over half a million shares, maintaining substantial alignment with shareholder interests. The sale does not alter board independence metrics or voting power materially. Lack of a disclosed trading plan may attract governance scrutiny, yet the transparency afforded by timely Form 4 filing fulfills Section 16 obligations. From a governance standpoint, risk remains low provided no repetitive large-scale liquidations follow.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIDZOS D JAMES

(Last) (First) (Middle)

12061 BLUEMONT WAY

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERISIGN INC/CA [ VRSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Chairman, Pres, & CEO

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		S		500	D	$280.567(1)	540,271.6215	D
Common Stock	06/17/2025		S		500	D	$281.573(2)	539,771.6215	D
Common Stock	06/17/2025		S		2,746	D	$284.0993(3)	537,025.6215	D
Common Stock	06/17/2025		S		1,254	D	$284.8211(4)	535,771.6215	D
Common Stock	06/18/2025		S		1,000	D	$280.8761(5)	534,771.6215	D
Common Stock	06/18/2025		S		1,500	D	$281.658(6)	533,271.6215	D
Common Stock	06/18/2025		S		1,400	D	$282.6859(7)	531,871.6215	D
Common Stock	06/18/2025		S		100	D	$283.75	531,771.6215	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $280.00 to $280.70, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $281.21 to $281.98, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $283.55 to $284.49, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $284.62 to $285.15, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $280.24 to $281.21, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

6. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $281.24 to $282.15, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

7. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $282.25 to $283.10, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

	Thomas C. Indelicarto by Power of Attorney for D. James Bidzos	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many VRSN shares did CEO D. James Bidzos sell?

He sold 9,000 common shares on 17-18 Jun 2025.

What was the price range for the VRSN insider sales?

Weighted-average prices ranged between $280.00 and $285.15 per share.

How many VRSN shares does the CEO still own after the transactions?

Bidzos beneficially owns 531,771.6215 shares following the reported sales.

Were any derivative securities involved in this Form 4 filing?

No, no derivative transactions were reported.

Does the filing mention a Rule 10b5-1 trading plan?

The document does not indicate that the sales were made under a Rule 10b5-1 plan.